Phase One Development Completed

NKC has announced the completion of the Phase One development for its new Huygens™ Smart Catheter and Proteus™ Robotic Arm Platform.

Frost & Sullivan Report on SBR Market

Global consulting firm Frost & Sullivan looks at potential market impact of the Neuro-Kinesis SmartBrain Retractor technology.

The SMART Tool Revolution

The development of SMART technologies for surgical tools coupled with advances in robotics is providing a revolution in creating better, safer and less invasive surgical options for patients.

Catheter Market Continues to Grow

The global catheter market expected to rise to $77.7B by 2026 with an average CAGR of 9.7% over the forecast period.

CGCI GLP Study Completed

The CGCI platform has successfully undergone a Good Laboratory Practice (GLP) animal study in advance of its next stage clinical trials.

CGCI Receives CE Marking for Sales in Europe

In December of 2011, the CGCI System received CE Marking certification. CE Marking enables the commercialization of CGCI in Europe and support certification in many other parts of the world. The scope of the indication for CGCI's CE Marking is "Design, manufacture,...

CGCI System Installed at Yonsei University Severance Hospital in Korea

A CGCI suite has been installed at the Yonsei University Severance Hospital in Seoul, South Korea. This installation represents the first such in the Asia market. Clinical trials will be conducted at the hospital using CGCI for mapping and ablation procedures...

First-In-Man Clinical Trials For CGCI Completed

The key benefits and the safety and effectiveness of the CGCI system have been further validated in a 40-patient human study that was recently completed under the direction of Dr. Jose Luis Merino Llorens, Director of the Arrhythmia–Electrophysiology Research Unit at...

Article on CGCI Published in the Journal of American Heart Association

The Journal of the American Heart Association, a peer-reviewed and open access scientific journal for the American Heart Association, published a paper entitled “Dynamically Shaped Magnetic Fields: Initial Animal Validation of a New Remote Electrophysiology Catheter...

Dr. Eli Gang Ranked Among America’s Best Doctors

Dr. Eli Gang, M.D., Chief Operating Officer of Neuro-Kinesis and Clinical Professor of Medicine, Geffen School of Medicine at UCLA, was ranked among America’s Top Doctors® according to a peer survey conducted by U.S. News & World Report magazine In the recently...

NKC News

The following articles and press releases are to provide information on the current status of the company as well as pertinent related articles on the EP industry. In addition, we also want to provide a historical perspective on the over 20 years of development that has preceded the advent of the new Huygens™ Smart Catheter and the Proteus™ Robotic Guidance System. NKC is very proud of its achievements in the field of advancing catheter mapping tools and guidance systems for the Electrophysiology field.

Specifically, all the articles related to the CGCI technology prior to 2015 relate to the prior work of the company under the Magnetecs banner and do not reflect the current NKC efforts except to show that the company has the ability to move their technology from invention to regulatory acceptance and then to real-world operation. The company is bringing this same expertise to bear on its revolutionary new Smart Catheter and Robotic Guidance System.

 

If you have any questions regarding any information you find here, please contact us at: info@neuro-kinesis.com

The SMART Tool Revolution

The SMART Tool Revolution

The development of SMART technologies for surgical tools coupled with advances in robotics is providing a revolution in creating better, safer and less invasive surgical options for patients.

CGCI Receives CE Marking for Sales in Europe

CGCI Receives CE Marking for Sales in Europe

In December of 2011, the CGCI System received CE Marking certification. CE Marking enables the commercialization of CGCI in Europe and support certification in many other parts of the world. The scope of the indication for CGCI's CE Marking is "Design, manufacture,...

First-In-Man Clinical Trials For CGCI Completed

First-In-Man Clinical Trials For CGCI Completed

The key benefits and the safety and effectiveness of the CGCI system have been further validated in a 40-patient human study that was recently completed under the direction of Dr. Jose Luis Merino Llorens, Director of the Arrhythmia–Electrophysiology Research Unit at...

Dr. Eli Gang Ranked Among America’s Best Doctors

Dr. Eli Gang Ranked Among America’s Best Doctors

Dr. Eli Gang, M.D., Chief Operating Officer of Neuro-Kinesis and Clinical Professor of Medicine, Geffen School of Medicine at UCLA, was ranked among America’s Top Doctors® according to a peer survey conducted by U.S. News & World Report magazine In the recently...